VA Research Wrap Up: New findings on tramadol, psychosis screening, MiliStories trial

VA News ·

VA Research highlights findings on tramadol usage, a psychosis screening to identify suicidal Veterans, and MiliStories for transitioning service members.

VA’s Office of Research and Development recently published three News Briefs highlighting a new study’s findings on tramadol co-prescriptions, a psychosis screening to identify suicidal Veterans, and MiliStories, a pilot messaging program for transitioning service members.

Tramadol is frequently co-prescribed with oxycodone or hydrocodone after surgery under the assumption that its dual mechanism of action provides an opioid-sparing benefit. However, VA Researchers in Nashville found this practice was associated with substantially more painkillers being consumed following surgery (as measured in morphine milligram equivalents) and reduced mobility when compared to oxycodone or hydrocodone alone.

The study used data from the IGNITE ADOPT-PGx Acute Pain trial, a multicenter, pragmatic, open-label clinical trial that recruited participants from eight U.S. health systems, which concluded in March 2024.

Future trials are needed to establish the optimal role of tramadol in postoperative analgesia, but this study showed using tramadol to enhance the pain relief of either oxycodone or hydrocodone may have the inverse effect.

Read more at Clinical Pharmacology & Therapeutics , Aug. 17, 2026.

VA Researchers at Bronx VA in New York created a novel screening system to help service members when leaving the military.

While most transitioning service members and Veterans are in the age range when psychotic disorders first emerge, Veterans living with psychotic disorders often do not seek healthcare services until long after the onset of illness.

Researchers created a first-of-its-kind standardized screening for psychotic symptoms, screening 5,019 transitioning service members at partnered U.S. military installations. Ten percent were assessed as positive, on average being nearly three times more likely to report lifetime suicidal ideation, more than four times more likely to report past suicide attempts, and approximately three times more likely to report depression and anxiety.

Of the 120 TSMVs with a positive screen who were contacted for follow-up, 55.8% initiated a brief clinical structured interview and all but one completed it. While only 12 participants were diagnosed with attenuated psychosis syndrome and five with threshold psychosis, the study showed psychosis screening could theoretically help 20,000 TSMVs annually to get the mental healthcare they need, sooner.

Read more at Psychiatric Services , Sept. 11, 2026.

For the first few years after a Veteran leaves military service, they are often unaware of all the options VA has to help them. With the goal of helping them start mental health treatment, VA researchers launched a remote clinical trial of a pilot program called MiliStories.

MiliStories features four brief video-based messages via a mobile app, playing once a week for a month. Veterans who received the messages were twice as likely to begin treatment by the follow-up two months later, demonstrating the promise a messaging service could have in connecting Veterans with the help they need, but might not know about.

Read more at American Journal of Public Health , Aug. 29, 2026.

For more Office of Research and Development updates, visit ORD online or go to https://www.research.va.gov/news_briefs/.

Источник: VA News